The HMG Co-A reductase inhibitors ('statins') and myotoxic effects

被引：0
|
作者：
机构：
[1] Med Control Council, Natl Adverse Drug Event Monitoring Ctr, Cape Town, South Africa
来源：
SAMJ SOUTH AFRICAN MEDICAL JOURNAL | 2002年 / 92卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：596 / 597
页数：2
相关论文
共 50 条
  • [21] Statins (HMG-CoA reductase inhibitors), cholesterol and stroke
    Marta-Moreno, J
    Echeandia, C
    Oliveros-Cid, A
    Figuerola, A
    Mola, S
    [J]. REVISTA DE NEUROLOGIA, 1998, 27 (159) : 827 - 830
  • [22] Effects of HMG-CoA reductase inhibitors on skeletal muscle - Are all statins the same?
    Evans, M
    Rees, A
    [J]. DRUG SAFETY, 2002, 25 (09) : 649 - 663
  • [23] Age-related macular degeneration and protective effect of HMG Co-A reductase inhibitors (statins): results from the National Health and Nutrition Examination Survey 2005–2008
    D T Q Barbosa
    T S Mendes
    H R Cíntron-Colon
    S Y Wang
    R B Bhisitkul
    K Singh
    S C Lin
    [J]. Eye, 2014, 28 : 472 - 480
  • [24] Modulating angiotensin II-induced inflammation by HMG Co-A reductase inhibition
    Dechend, R
    Fiebler, A
    Lindschau, C
    Bischoff, H
    Müller, D
    Park, JK
    Dietz, R
    Haller, H
    Luft, FC
    [J]. AMERICAN JOURNAL OF HYPERTENSION, 2001, 14 (06) : 55S - 61S
  • [25] Lipid-lowering effect of HMG co-A reductase inhibitors compared with cholestyramines on vascular enclothelium in hypercholesterolemic and hypertensive patients
    Park, SJ
    Choi, DJ
    Hwang, JY
    [J]. CIRCULATION, 2004, 110 (17) : 119 - 119
  • [26] The efficacy of ezetimibe in renal transplant recipients intolerant to or not reaching cholesterol lower goals with HMG CO-A reductase inhibitors.
    Langone, AJ
    Chuange, P
    Schaefer, HM
    Kizilisik, T
    Shaffer, D
    Helderman, JH
    Nylander, W
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 : 469 - 469
  • [27] ALLEVIATION OF SIDE-EFFECTS OF ANTICANCER THERAPEUTICS BY HMG-COA REDUCTASE INHIBITORS (STATINS)
    Damrot, Julia
    Ostrau, Christian
    Huelsenbeck, Johannes
    Herzog, Melanie
    Nuebel, Tobias
    Kaina, Bernd
    Fritz, Gerhard
    [J]. ANTICANCER RESEARCH, 2008, 28 (5C) : 3284 - 3285
  • [28] Age-related macular degeneration and protective effect of HMG Co-A reductase inhibitors (statins): results from the National Health and Nutrition Examination Survey 2005-2008
    Barbosa, D. T. Q.
    Mendes, T. S.
    Cintron-Colon, H. R.
    Wang, S. Y.
    Bhisitkul, R. B.
    Singh, K.
    Lin, S. C.
    [J]. EYE, 2014, 28 (04) : 472 - 480
  • [29] HMG-CoA reductase inhibitors (statins) as anticancer drugs (Review)
    Fritz, G
    [J]. INTERNATIONAL JOURNAL OF ONCOLOGY, 2005, 27 (05) : 1401 - 1409
  • [30] Cerivastatin, a new synthetic HMG CO-A reductase inhibitor in the treatment of patients with primary hyperlipidaemia
    Kukharchuk, VV
    Solovieva, EY
    Rozhkova, TA
    Tvorogova, MG
    [J]. ATHEROSCLEROSIS, 1999, 144 : 196 - 197
12345